Pyrexia - PACT - ESICM
Pyrexia - PACT - ESICM
Pyrexia - PACT - ESICM
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Self-assessment<br />
SELF-ASSESSMENT<br />
EDIC-style Type K<br />
1. Clinical signs or measurements associated with fever include:<br />
A. Rigor<br />
B. Increased oxygen consumption<br />
C. Decreased energy expenditure<br />
D. Tachycardia<br />
2. Fever in a patient on the second day after major trauma:<br />
A. Is a common phenomenon<br />
B. Is abnormal when it occurs<br />
C. Is a strong indication of an infection<br />
D. Usually does not exceed 38.5 C<br />
3. Fever above 39 C in a patient with head injury<br />
A. Is normal and does not need treatment<br />
B. May increase cerebral damage<br />
C. Should immediately be treated with broad-spectrum antibiotics<br />
D. Acetaminophen (paracetamol) is the first treatment of choice<br />
4. Clinical manifestations of heat stroke include<br />
A. Core temperature above 42 C required for diagnosis<br />
B. Reduced consciousness<br />
C. Convulsions<br />
D. Hypertension<br />
5. The Neuroleptic Malignant syndrome is caused by:<br />
A. Mutation in calcium channels of sarcoplasmatic reticulum<br />
B. Excessive stimulation of beta receptors in the musculature<br />
C. Drug-induced blockade of dopamine receptors<br />
D. Inactive Na/K channels in myocytes<br />
6. Safe drugs to use in a patient at risk of malignant hyperthermia<br />
include:<br />
A. Thiopentone (thiopental)<br />
B. Propofol<br />
C. Succinylcholine<br />
D. Lignocaine<br />
7. Important pathways responsible for increasing heat production and<br />
temperature include:<br />
A. Activation of arachidonic acid metabolites<br />
B. Down-regulation of prostaglandin levels<br />
C. Activation of α receptor activity<br />
D. Increase in cyclo-oxygenase-2 (COX-2) pathway activity<br />
[46]